CIK 0001824893
- Non-accelerated filer
- Smaller reporting company
Surrozen, Inc./DE
Sign in to watch- Ticker
- SRZN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 301374889
- Phone
- +1 650-475-2820
- Business address
- 171 OYSTER POINT BLVD, SUITE 400, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Consonance-HFW Acquisition Corp.
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Insider Changes in Ownership
- 4 Grant or award Former 10% Holder acquired 1,885,000 shares (grant or award)
- 4 Grant or award Former Director acquired 30,000 shares (grant or award)
- 4 Insider Changes in Ownership
- 4 Grant or award Former Director acquired 30,000 shares (grant or award)
- 4 Grant or award Former Director acquired 30,000 shares (grant or award)
- 4 Grant or award FORMER DIRECTOR acquired 1,885,000 shares (grant or award)
- 4 Grant or award Former Chief Financial Officer acquired 1,885,000 shares (grant or award)
- 4 Grant or award 10% owner acquired 3,497,500 shares (grant or award)
- 4/A Open-market sale Director sold 90,000 shares at $0.01 ($981)
- 4/A Open-market sale Director sold 90,000 shares at $0.01 ($981)
Page 8 of 10 · 189 filings